SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,293,000 | -82.0% | 30,000 | -87.0% | 0.19% | -83.7% |
| Q1 2017 | $7,199,000 | +14.0% | 230,000 | -8.0% | 1.14% | -5.8% |
| Q4 2016 | $6,313,000 | -99.9% | 250,000 | -7.4% | 1.21% | +14.0% |
| Q3 2016 | $6,677,100,000 | +116960.0% | 270,000 | -3.6% | 1.06% | +4.7% |
| Q2 2016 | $5,704,000 | +38.5% | 280,000 | +3.7% | 1.01% | +24.0% |
| Q1 2016 | $4,118,000 | +6.4% | 270,000 | -6.2% | 0.82% | +39.7% |
| Q4 2015 | $3,871,000 | -21.9% | 288,000 | -18.5% | 0.58% | -25.9% |
| Q3 2015 | $4,957,000 | -30.0% | 353,328 | -15.3% | 0.79% | -7.1% |
| Q2 2015 | $7,081,000 | +29.9% | 417,000 | -7.5% | 0.85% | -7.5% |
| Q1 2015 | $5,450,000 | +161.8% | 450,800 | +79.7% | 0.92% | +52.4% |
| Q4 2014 | $2,082,000 | +13.0% | 250,800 | +18.3% | 0.60% | +11.9% |
| Q3 2014 | $1,842,000 | -25.9% | 212,000 | -6.6% | 0.54% | -27.0% |
| Q2 2014 | $2,486,000 | +41.5% | 227,000 | +15.5% | 0.74% | +40.0% |
| Q1 2014 | $1,757,000 | +3.5% | 196,537 | -12.7% | 0.53% | -20.6% |
| Q4 2013 | $1,697,000 | – | 225,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |